Funding Rounds
CatalYm

CatalYm Unknown (2022, $51M)

CatalYm

Innovative immunotherapies developer for cancer patients.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $51.55M

Investors